β-blockers in Chronic Obstructive Pulmonary Disease: a Cohort Study from the TONADO<sup>®</sup> Research Programme.
| Author | |
|---|---|
| Abstract | :
Cardiovascular disease is a frequent co-morbidity in patients with chronic obstructive pulmonary disease (COPD). Many clinicians, particularly pulmonologists, are reluctant to use β-adrenoceptor blocking agents (β-blockers) in patients with COPD, despite their proven effectiveness in preventing cardiovascular events. |
| Year of Publication | :
2018
|
| Journal | :
Chest
|
| Date Published | :
2018
|
| ISSN Number | :
0012-3692
|
| URL | :
http://linkinghub.elsevier.com/retrieve/pii/S0012-3692(18)30080-1
|
| DOI | :
10.1016/j.chest.2018.01.008
|
| Short Title | :
Chest
|
| Download citation |